Persistence and adherence with mirabegron versus antimuscarinics in overactive bladder: retrospective analysis of a UK General Practice Prescription Database

被引:0
|
作者
Wagg, Adrian [1 ]
Foley, Steve [2 ]
Peters, John [3 ]
Nazir, Jameel [4 ]
Kool-Houweling, Leanne [5 ]
Scrine, Ludmila [6 ]
机构
[1] Univ Alberta, Med, Edmonton, AB, Canada
[2] Royal Berkshire Hosp, Dept Urol, Reading, Berks, England
[3] Barts Hlth NHS Trust, Whipps Cross Hosp, Dept Urol, London, England
[4] Astellas Pharma Europe Ltd, Hlth Econ & Outcomes Res, Chertsey, England
[5] Quintiles Advisory Serv, Hoofddorp, Netherlands
[6] Astellas Pharma Europe, Chertsey, England
关键词
D O I
10.1016/j.ejogrb.2017.01.028
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
2
引用
收藏
页码:199 / 200
页数:2
相关论文
共 50 条
  • [41] Comparison of persistence among therapies for overactive bladder: A retrospective pharmacy claims analysis
    Cisternas, M
    Noe, L
    Patel, B
    Remigio-Baker, R
    Williamson, T
    Black, L
    NEUROUROLOGY AND URODYNAMICS, 2005, 24 (5-6) : 580 - 581
  • [42] Adherence and Persistence with Once-Daily Teriparatide in Japan: A Retrospective, Prescription Database, Cohort Study
    Tanaka, Ikuko
    Sato, Masayo
    Sugihara, Tomoko
    Faries, Douglas E.
    Nojiri, Shuko
    Graham-Clarke, Peita
    Flynn, Jennifer A.
    Burge, Russel T.
    JOURNAL OF OSTEOPOROSIS, 2013, 2013
  • [43] MIRABEGRON VERSUS TOLTERODINE FOR THE TREATMENT OF OVERACTIVE BLADDER: A META-ANALYSIS OF FIVE RANDOMIZED CONTROLLED TRIALS
    Naser, O.
    Elgebaly, A.
    Elfil, M.
    Mahmoud, A.
    Negida, A.
    Rashad, Y.
    Rashad, M.
    Abd Elsalam, A. E.
    Elkohly, S.
    Abdelrahman, A.
    Gana, B.
    NEUROUROLOGY AND URODYNAMICS, 2015, 34 : S403 - S404
  • [44] Antimuscarinic persistence patterns in newly treated patients with overactive bladder: a retrospective comparative analysis
    Antoni Sicras-Mainar
    Javier Rejas
    Ruth Navarro-Artieda
    Alba Aguado-Jodar
    Amador Ruiz-Torrejón
    Jordi Ibáñez-Nolla
    Marion Kvasz
    International Urogynecology Journal, 2014, 25 : 485 - 492
  • [45] Antimuscarinic persistence patterns in newly treated patients with overactive bladder: a retrospective comparative analysis
    Sicras-Mainar, Antoni
    Rejas, Javier
    Navarro-Artieda, Ruth
    Aguado-Jodar, Alba
    Ruiz-Torrejon, Amador
    Ibanez-Nolla, Jordi
    Kvasz, Marion
    INTERNATIONAL UROGYNECOLOGY JOURNAL, 2014, 25 (04) : 485 - 492
  • [46] Prescription Patterns in Asthma Patients Initiating Salmeterol in UK General PracticeA Retrospective Cohort Study using the General Practice Research Database (GPRD)
    Rachael L. Di Santostefano
    Kourtney J. Davis
    Drug Safety, 2011, 34 : 511 - 520
  • [47] Persistence and adherence to overactive bladder medications in Japan: A large nationwide real-world analysis
    Kato, Daisuke
    Uno, Satoshi
    Van Schyndle, James
    Fan, Alan
    Kimura, Tomomi
    INTERNATIONAL JOURNAL OF UROLOGY, 2017, 24 (10) : 757 - 764
  • [48] Persistence with osteoporosis medications among postmenopausal women in the UK General Practice Research Database
    Li, Lin
    Roddam, Andrew
    Gitlin, Matthew
    Taylor, Andrew
    Shepherd, Susan
    Shearer, Arran
    Jick, Susan
    MENOPAUSE-THE JOURNAL OF THE NORTH AMERICAN MENOPAUSE SOCIETY, 2012, 19 (01): : 33 - 40
  • [49] ASSESSING PERSISTENCE IN PATIENTS WITH OVERACTIVE BLADDER PRESCRIBED MIRABEGRON IN ROUTINE CLINICAL PRACTICE: SUBANALYSIS OF A PAN-EUROPEAN NON-INTERVENTIONAL STUDY
    Foley, S.
    Freeman, R.
    Rosa, J.
    Vicente, E.
    Huang, M.
    Stari, A.
    Bowditch, S.
    Choudhury, N.
    NEUROUROLOGY AND URODYNAMICS, 2017, 36 : S301 - S302
  • [50] COST-EFFECTIVENESS ANALYSIS OF MIRABEGRON VERSUS TOLTERODINE EXTENDED RELEASE IN THE TREATMENT OF PATIENTS WITH OVERACTIVE BLADDER IN THE UNITED STATES
    Xie, J.
    Zhou, Z. Y.
    Bui, C. N.
    Yan, Y.
    De, G.
    Runken, M. C.
    Wu, E. Q.
    VALUE IN HEALTH, 2012, 15 (07) : A457 - A457